Results 1 to 10 of about 2,259,005 (145)

Minimally Invasive Glaucoma Surgery: A Review of the Literature

Vision, 2023
Minimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP).
Michael Balas, David J. Mathew
doaj   +5 more sources

Minimally Invasive Glaucoma Surgery (MIGS)

Delhi Journal of Ophthalmology, 2021
Glaucoma, a chronic progressive optic neuropathy, is the second leading cause of irreversible blindness world-wide. The only treatable risk factor till date is lowering of intra-ocular pressure (IOP), thus, being the mainstay of treatment.
Meena G Menon, Shalini
doaj   +6 more sources

Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma

Therapeutic Advances in Ophthalmology, 2023
Background: Minimally invasive glaucoma procedures are emerging as clinically effective and safe glaucoma management approaches; however, evidence regarding quality-of-life outcomes is limited.
Lee Jones, Natalia Maes, Umair Qidwai, Gokulan Ratnarajan   +3 more
doaj   +2 more sources

Global tendency and research trends of minimally invasive surgery for glaucoma from 1992 to 2023: A visual bibliometric analysis

Heliyon
Background: Minimally invasive glaucoma surgery has become a popular research topic over the past decade. However, no published studies have provided a systematic overview for this field.
Ruyue Li, Hanruo Liu, Kaiwen Zhang, Zhecheng Lu, Ningli Wang   +4 more
doaj   +3 more sources

Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?

Clinical Ophthalmology, 2020
Ciro Costagliola,1 Mario Sbordone,2 Stefano Gandolfi,3 Luca Cesari,4 Gianluca Furneri,5 Antonio Maria Fea6 1Department of Medicine & Health Sciences “V.
Costagliola C, Sbordone M, Gandolfi S, Cesari L, Furneri G, Fea AM   +5 more
doaj   +2 more sources

Trends in operating room-based glaucoma procedures at a single eye center from 2016–2020 [PDF]

International Journal of Ophthalmology, 2023
AIM: To evaluate trends in glaucoma procedures at the Peking University Eye Center in 2016–2020. METHODS: A retrospective search of all glaucoma procedures performed at our institution were performed.
Di Zhang, Jin-Hong Miao, Ling-Ge Suo, Ya-Nan Li, Xu-Hao Chen, De-Fu Wu, Qian-Ru Wu, Chun Zhang   +7 more
doaj   +1 more source

Hypotensive Treatment of Glaucoma — Minimally Invasive Surgery. Literature review

Oftalʹmologiâ, 2022
Glaucoma continues to be the disease leading to vision loss and blindness. Currently, various treatment options are offered for persistent compensation of intraocular pressure, as the main cause of the glaucoma optic neuropathy development.
M. A. Melnik, V. R. Mamikonyan, O. A. Shmeleva-Kenoufi, A. I. Mukha   +3 more
doaj   +1 more source

First XEN implantation in Axenfeld- Rieger syndrome: A case report and literature review

American Journal of Ophthalmology Case Reports, 2022
Purpose: To present the first report of a XEN45 gel stent implantation in a female with Axenfeld-Rieger syndrome (ARS), a rare congenital anomaly caused by abnormal neural crest migration during early embryogenesis.
Liat Mendel, Ron Eremenko, Lilly Zborowski- Naveh, Maya Kalev -Landoy   +3 more
doaj   +1 more source

Is XEN-glaucoma gel microstent safe enough in phakic eyes?

Indian Journal of Ophthalmology. Case Reports, 2022
Minimally invasive glaucoma surgery (MIGS) is usually preferred as it causes less complications in glaucoma surgery. XEN Glaucoma Gel Microstent (XEN-GGM, Allergan Plc., Parsippany, New Jersey) is one of the MIGS used in glaucoma surgery.
Oksan Alpogan
doaj   +1 more source

Impact of glaucoma and glaucoma surgery on quality of life [PDF]

Клиническая офтальмология, 2022
V.P. Erichev, A.V. Volzhanin Scientific Research Institute of Eye Diseases, Moscow, Russian Federation Glaucoma is a chronic, incurable disease managed by controlling intraocular pressure (IOP).
V.P. Erichev, A.V. Volzhanin
doaj